Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-09-18

Clinical Trial Update: Treatment of Bifurcated Coronary Lesions With Cypher™-Stent [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the Cypher sirolimus-eluting stent for bifurcated coronary lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cypher Stent (sirolimus-eluting stent)

Snippet

Sponsor: University Heart Center Freiburg - Bad Krozingen | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN